Concepedia

Melinda S. Yates

MS

35

Publications

3.7K

Citations

27

H-Index

2006

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Johns Hopkins University

Dartmouth College

Johns Hopkins Medicine

Tohoku University

Melinda S. Yates is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, obstetrics, and pharmacology.

ORCID

Top concepts

Publications per year

2006–2024

35

Publications

35

Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide

Rajesh K. Thimmulappa, Catherine Scollick, Kassim Traore et al. · Biochemical and Biophysical Research Communications · 2006 · 347 citations · Full text

, , +13

Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice

Thomas E. Sussan, Tirumalai Rangasamy, David J. Blake et al. · Proceedings of the National Academy of Sciences · 2008 · 343 citations · Full text

, , +20

Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma

Brian M. Slomovitz, Yunyun Jiang, Melinda S. Yates et al. · Journal of Clinical Oncology · 2015 · 312 citations · Full text

Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes

Melinda S. Yates, Masafumi Tauchi, Fumiki Katsuoka et al. · Molecular Cancer Therapeutics · 2007 · 292 citations · Full text

Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide

Soona Shin, Junko Wakabayashi, Melinda S. Yates et al. · European Journal of Pharmacology · 2009 · 273 citations · Full text

, , +11

Rows per page

1–5 of 35